logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/08/2026
The CSI 1000 Index futures main contract rose 2% during the day, currently reported at 7803.40 points.
Latest
3 m ago
Lei Jun: On March 28, 2024, the Xiaomi SU7 was officially released. As of today, in just 28.5 months, the delivery volume of the Xiaomi SU7 series has exceeded 500,000 units.
3 m ago
On August 17, AstraZeneca announced the official launch of Tezspire (generic name: tezelizumab injection) in China. In March 2026, tezelizumab was approved in China for two indications based on positive results from the DIRECTION and WAYPOINT Phase III clinical studies: for the maintenance treatment of severe asthma in adults and adolescents aged 12 years and older; and in combination with intranasal corticosteroids, for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP) whose disease is not adequately controlled by systemic corticosteroids and/or surgery.
4 m ago
Hong Kong Stock Movement | China Qinfa (00866.HK) rises nearly 15% again, expects post-tax profit for the first half of the year to be no more than 290 million yuan.
4 m ago
Establishing a high-quality development model in the industry, Geely Automobile's revenue in the first half of 2026 exceeded 170 billion yuan, with a core net profit attributable to shareholders soaring by 46%.
5 m ago
AstraZeneca announces the official launch of Tezspire in China.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.